8-K
filed January 2, 2025, 6:59 PM ET
CIK 0001183765
other material
confidence high
sentiment negative
materiality 1.00
Molecular Templates initiates wind-down; entire board and CEO resign
Molecular Templates, Inc.
- All six directors (Selick, Hoffmann, Lalande, Poma, Gruia, Sanders) resigned effective Dec 31, 2024.
- CEO Eric Poma resigned with no severance; vesting of options continues to Mar 31, 2025; consulting at $500/hr.
- Craig Jalbert appointed sole director and officer for wind-down; to be paid $150,000.
- Board approved wind-down effective Dec 31, 2024; company warns holders unlikely to receive value.
- Company expects insufficient resources to continue SEC reporting obligations.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Eric E. Poma resigned as Chief Executive Officer, Chief Scientific Officer, Treasurer and Interim Chief Financial Officer at Molecular Templates, Inc..
- Action
- resigned
- Role
- Chief Executive Officer, Chief Scientific Officer, Treasurer and Interim Chief Financial Officer
Exact text from the filing
Additionally, Dr. Poma resigned from his roles as Chief Executive Officer, Chief Scientific Officer, Treasurer and Interim Chief Financial Officer of the Company effective as of 11:59 pm EST on December 31, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Harold E. Selick resigned as Director at Molecular Templates, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On December 31, 2024, Harold E. Selick, David R. Hoffmann, Kevin M. Lalande, Eric E. Poma, Gabriela Gruia, and Corsee Sanders each resigned from the Board of Directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
David R. Hoffmann resigned as Director at Molecular Templates, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On December 31, 2024, Harold E. Selick, David R. Hoffmann, Kevin M. Lalande, Eric E. Poma, Gabriela Gruia, and Corsee Sanders each resigned from the Board of Directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Kevin M. Lalande resigned as Director at Molecular Templates, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On December 31, 2024, Harold E. Selick, David R. Hoffmann, Kevin M. Lalande, Eric E. Poma, Gabriela Gruia, and Corsee Sanders each resigned from the Board of Directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Gabriela Gruia resigned as Director at Molecular Templates, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On December 31, 2024, Harold E. Selick, David R. Hoffmann, Kevin M. Lalande, Eric E. Poma, Gabriela Gruia, and Corsee Sanders each resigned from the Board of Directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Craig Jalbert was appointed as sole director, President, Chief Executive Officer, Treasurer and Chief Financial Officer at Molecular Templates, Inc..
- Action
- appointed
- Role
- sole director, President, Chief Executive Officer, Treasurer and Chief Financial Officer
Exact text from the filing
Effective as of 12:00 am EST on January 1, 2025, the Board appointed Craig Jalbert, age 63, as sole director, President, Chief Executive Officer, Treasurer and Chief Financial Officer of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Eric E. Poma resigned as Director at Molecular Templates, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On December 31, 2024, Harold E. Selick, David R. Hoffmann, Kevin M. Lalande, Eric E. Poma, Gabriela Gruia, and Corsee Sanders each resigned from the Board of Directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Corsee Sanders resigned as Director at Molecular Templates, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On December 31, 2024, Harold E. Selick, David R. Hoffmann, Kevin M. Lalande, Eric E. Poma, Gabriela Gruia, and Corsee Sanders each resigned from the Board of Directors
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.